Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VETAL is a Turkey-based animal health company focused on veterinary vaccines, hyperimmune sera, and diagnostic products for livestock, companion animals, equine health, and aquaculture. Founded in 1991 in Adıyaman, it describes itself as the country’s first private-sector investment in vaccine and biological material production and operates a GMP-certified manufacturing facility. The company markets more than 60 products and exports to more than 30 countries. Its portfolio spans live and inactivated veterinary vaccines, sera, antigens, and facility-specific autovaccines, with products for cattle, sheep and goats, horses, cats and dogs, and fish. VETAL also conducts ongoing R&D and field studies and has created PRIMEVAC as a specialized fish-vaccine unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vetal Animal Health Products.